The Use of Bedaquiline in the Treatment of Multi-Drug Resistant Tuberculosis: Interim Policy Guidance

This interim guidance provides advice on the inclusion of bedaquiline in the combination therapy of MDR-TB in accordance with the existing WHO Guidelines for the Programmatic Management of Drug-resistant TB (2011 Update).